The Research Progress of LncRNA in Osteoarthritis: Mechanisms and Clinical Applications

Yanggang Tang; Peng Ling; Zunian He; Zhou Qin; Zhenyan Qian; Dinggui  Lu

doi:10.54097/at7v6f20

Authors

Yanggang Tang
Peng Ling
Zunian He
Zhou Qin
Zhenyan Qian
Dinggui Lu

DOI:

https://doi.org/10.54097/at7v6f20

Keywords:

LncRNA, Osteoarthritis, Pathogenesis, Biomarker, Therapeutic Target

Abstract

In recent years, long non-coding RNA (LncRNA) has garnered widespread attention in the study of osteoarthritis (OA). LncRNA not only plays an important role in the pathogenesis of OA, but also may serve as a potential biomarker and therapeutic target. A large number of studies have shown that LncRNA regulates inflammatory responses and cartilage degeneration, playing a critical role in the pathogenesis of OA. Meanwhile, the expression and function of LncRNA in chondrocytes, macrophages, and fibroblasts have been extensively studied, revealing its importance in cell-cell interactions. The potential of LncRNA as a biomarker has also been preliminarily validated, especially in early diagnosis and assessment of disease severity. Furthermore, the prospects of gene silencing technology and other intervention approaches in targeted LncRNA therapy are promising. However, LncRNA research still faces technical challenges and obstacles in clinical translation. This review summarizes the latest research progress of LncRNA in osteoarthritis, discusses its role mechanisms, relationship with inflammatory responses, effects on chondrocyte metabolism, and potential as a biomarker and therapeutic target, providing a new perspective for future research and clinical applications.

Downloads

Download data is not yet available.

References

[1] Dai GD, Wang PM, Cai JP, Yan SH, Xia H: [Research progress on long non-coding RNA (lncRNA) in osteoarthritis]. Zhongguo Gu Shang 2020, 33:1085-1088.

[2] Wang R, Shiu HT, Lee WYW: Emerging role of lncRNAs in osteoarthritis: An updated review. Front Immunol 2022, 13:982773.

[3] Katsushima K, Jallo G, Eberhart CG, Perera RJ: Long non-coding RNAs in brain tumors. NAR Cancer 2021, 3: zcaa041.

[4] Wu G, Du X, Li Z, Du Y, Lv J, Li X, Xu Y, Liu S: The emerging role of long non-coding RNAs in schizophrenia. Front Psychiatry 2022, 13:995956.

[5] Xin C, Liu J: Long Non-coding RNAs in Parkinson's Disease. Neurochem Res 2021, 46:1031-1042.

[6] Aryee DNT, Fock V, Kapoor U, Radic-Sarikas B, Kovar H: Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis. Cells 2022, 11.

[7] Rashidmayvan M, Sahebi R, Ghayour-Mobarhan M: Long non-coding RNAs: a valuable biomarker for metabolic syndrome. Mol Genet Genomics 2022, 297:1169-1183.

[8] Núñez-Carro C, Blanco-Blanco M, Villagrán-Andrade KM, Blanco FJ, de Andrés MC: Epigenetics as a Therapeutic Target in Osteoarthritis. Pharmaceuticals (Basel) 2023, 16.

[9] Liu Y, Jing J, Yu H, Zhang J, Cao Q, Zhang X, Liu J, Zhang S, Cheng W: Expression profiles of long non-coding RNAs in the cartilage of patients with knee osteoarthritis and normal individuals. Exp Ther Med 2021, 21:365.

[10] Ghafouri-Fard S, Taheri M: Long non-coding RNA signature in gastric cancer. Exp Mol Pathol 2020, 113:104365.

[11] Lv Y, Wang Y, Zhang Z, Bao J, Su H: Potentials of long non-coding RNAs as biomarkers of colorectal cancer. Clin Transl Oncol 2022, 24:1715-1731.

[12] Bhardwaj V, Tan YQ, Wu MM, Ma L, Zhu T, Lobie PE, Pandey V: Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives. Cancer Lett 2021, 502:97-107.

[13] Yang Y, Xing D, Wang Y, Jia H, Li B, Li JJ: A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway. BMC Mol Cell Biol 2020, 21:53.

[14] Wang Y, Xue M, Xia F, Zhu L, Jia D, Gao Y, Li L, Shi Y, Li Y, Chen S, et al: Long Non-Coding RNA GAS5 in Age-Related Diseases. Curr Med Chem 2022, 29:2863-2877.

[15] Wang W, Min L, Qiu X, Wu X, Liu C, Ma J, Zhang D, Zhu L: Biological Function of Long Non-coding RNA (LncRNA) Xist. Front Cell Dev Biol 2021, 9:645647.

[16] He L, Li Y, Wang G, Li C: [Regulation of long non-coding RNA in cartilage injury of osteoarthritis]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2020, 34:1486-1491.

[17] Yoon DS, Kim EJ, Cho S, Jung S, Lee KM, Park KH, Lee JW, Kim SH: RUNX2 stabilization by long non-coding RNAs contributes to hypertrophic changes in human chondrocytes. Int J Biol Sci 2023, 19:13-33.

[18] Tan F, Wang D, Yuan Z: The Fibroblast-Like Synoviocyte Derived Exosomal Long Non-coding RNA H19 Alleviates Osteoarthritis Progression Through the miR-106b-5p/TIMP2 Axis. Inflammation 2020, 43:1498-1509.

[19] Chen L, Xu J, Lv S, Zhao Y, Sun D, Zheng Y, Li X, Zhang L, Chi G, Li Y: Overexpression of long non-coding RNA AP001505.9 inhibits human hyaline chondrocyte dedifferentiation. Aging (Albany NY) 2021, 13:11433-11454.

[20] Ni C, Zhang W, Qiu S, Cheng H, Ma C: Long Non-coding RNA DLEU1 Promotes Progression of Osteoarthritis via miR-492/TLR8 Axis. Curr Pharm Biotechnol 2024.

[21] Zou H, Lu C, Qiu J: Long non-coding RNA LINC00265 promotes proliferation, apoptosis, and inflammation of chondrocytes in osteoarthritis by sponging miR-101-3p. Autoimmunity 2021, 54:526-538.

[22] Kreimendahl S, Rassow J: The Mitochondrial Outer Membrane Protein Tom70-Mediator in Protein Traffic, Membrane Contact Sites and Innate Immunity. Int J Mol Sci 2020, 21.

[23] Ferreira C, Viana SD, Reis F: Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches. Microorganisms 2020, 8.

[24] Liang Y, Meng Z, Chen Y, Zhang Y, Wang M, Zhou X: A Data Fusion Orientation Algorithm Based on the Weighted Histogram Statistics for Vector Hydrophone Vertical Array. Sensors (Basel) 2020, 20.

[25] Scherger M, Bolli E, Antunes ARP, Arnouk S, Stickdorn J, Van Driessche A, Schild H, Grabbe S, De Geest BG, Van Ginderachter JA, Nuhn L: Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels. Cells 2020, 9.

[26] Santacroce L, Charitos IA, Ballini A, Inchingolo F, Luperto P, De Nitto E, Topi S: The Human Respiratory System and its Microbiome at a Glimpse. Biology (Basel) 2020, 9.

[27] Iro MA, Soundara Pandi SP: Clinical application of non-coding RNAs in sepsis. Curr Opin Infect Dis 2020, 33:530-539.

[28] Chen Y, Li Z, Chen X, Zhang S: Long non-coding RNAs: From disease code to drug role. Acta Pharm Sin B 2021, 11:340-354.

[29] Tang Y, He X: Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications. Mol Cell Biochem 2021, 476:3537-3550.

[30] Han S, Chen X, Huang L: The tumor therapeutic potential of long non-coding RNA delivery and targeting. Acta Pharm Sin B 2023, 13:1371-1382.

[31] Shi D, Mei Y, Hao W, Li J, Liu S, Lin X: Biological functions and applications of LncRNAs in the regulation of the extracellular matrix in osteoarthritis. Front Cell Dev Biol 2023, 11:1330624.

[32] Tu J, Chen Y, Li Z, Yang H, Chen H, Yu Z: Long non-coding RNAs in ovarian granulosa cells. J Ovarian Res 2020, 13:63.

[33] Xu J, Yin Y, Lin Y, Tian M, Liu T, Li X, Chen S: Long non-coding RNAs: Emerging roles in periodontitis. J Periodontal Res 2021, 56:848-862.

[34] Yang X, Xie Z, Lei X, Gan R: Long non-coding RNA GAS5 in human cancer. Oncol Lett 2020, 20:2587-2594.